Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.
CONCLUSION: Canagliflozin prevents endothelial dysfunction and atherogenesis in diabetic ApoE-/- mice. Anti-inflammatory and antioxidative potential due to reduced glucose toxicity to endothelial cells might be its underlying mechanisms.
PMID: 32101837 [PubMed - as supplied by publisher]
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Tags: J Atheroscler Thromb Source Type: research
More News: Canagliflozin | Cardiology | Cardiovascular | Cholesterol | Diabetes | Endocrinology | Heart | Invokana | Sodium | Study | Sudan Health | Thrombosis | Toxicology